Source: International Congress 2014 – Respiratory symptoms in primary care populations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Suggett, N. Mark, D. Cathy, A. Rubina, J. Mitchell (London, Canada). Delivery of medication by breath-actuated nebulizer (BAN) is similar when used with differing inhalation / exhalation ratios: A contrast to breath enhanced nebulizer (BEN) behavior. Eur Respir J 2014; 44: Suppl. 58, 3819

Member's Comments

No comment yet.

Related content which might interest you: Valved holding chambers (VHCs) can have different medication delivery performance as a function of delay interval following actuation of the pressurized metered dose inhaler (pMDI) Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 Satisfaction survey on the use of breath actuated Inhaler Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Sealed-lips instruction for pressurised metered dose inhalers (pMDIs) – A critical step? Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care Year: 2014 Inspiratory flow resistance of marketed dry powder inhalers (DPI) Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 INhaler compliance assessment in the community (INCA GP) Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care Year: 2014 The effect of inhalation duration on lung deposition with a pressurized metered-dose inhaler (pMDI) Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Canadian physicians are concerned about the use of inhaled corticosteroids (ICS) in COPD management Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care Year: 2014 LATE-BREAKING ABSTRACT: Effectiveness of training session on the inhalation technique of the BA-pMDI Autohaler® (containing beclometasone) in daily practice. Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals Year: 2013 Comparison of asthma and COPD patients' perception of appropriate metered-dose inhaler technique with a questionnaire and supervision based reference standard Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild–severe asthma and severe COPD Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 LATE-BREAKING ABSTRACT: Profiling of single maintenance and reliever therapy (SMART) dosing instructions of budesonide/formoterol (BFC) in clinical practice Source: International Congress 2014 – Management of COPD in primary care Year: 2014 Prevalence of serious post-training inhaler technique errors made by device-naïve patients using three different dry powder inhalers (DPIs) Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Changing a hospital inhaler policy to improve in-hospital inhaler use Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Comparing pharmacist time use for asthma and COPD patients using various types of inhaler devices Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Evaluation of COPD-6 device for detecting airflow limitation and predicting clinical diagnosis Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 Innovative dry powder inhaler (DPI) shows improved cost-effectiveness compared with current DPIs for asthma therapy in UK primary care Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 The performance of a new vibrating mesh prototype nebulizer for inhaled biodrugs Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 GP survey on how to incorporate LABA/LAMA fixed dose combinations (FDC) in their COPD patients Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014 Evaluation of peak flow meter for detecting airflow limitation and predicting clinical diagnosis Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 No differences? Aerosol characteristics of 9 jet nebulisers tested in vitro Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014